Table 5.
Unadjusted | Adjusted b | |||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
5-y OS | ||||
Any barrier | 1.57 (0.81-3.02) | .181 | 2.34 (0.92-5.97) | .075 |
Delay only | 1.59 (0.71-3.59) | .257 | 1.91 (0.74-4.95) | .182 |
Affordability only | 1.54 (0.46-5.15) | .484 | 2.45 (0.81-7.45) | .114 |
Delay and affordability | 1.53 (0.53-4.43) | .438 | 1.91 (0.61-6.05) | .269 |
5-y CSS | ||||
Any barrier | 1.26 (0.60-2.62) | .542 | 2.48 (0.88-6.95) | .084 |
Delay only | 1.53 (0.65-3.62) | .332 | 1.82 (0.60-5.56) | .290 |
Affordability only | 1.68 (0.50-5.65) | .404 | 1.48 (0.39-5.52) | .563 |
Delay and affordability | 0.42 (0.06-3.12) | .395 | 3.48 (0.92-13.26) | .067 |
Abbreviations: CSS, cancer-specific survival; HR, hazard ratio; OS, overall survival.
Reference variable is “no barriers” for all models.
Adjusted for age, sex, race, marital status, education, insurance status, employment status, distance to hospital, history of tobacco use, history of alcohol use, comorbid depression, comorbid anxiety, tumor site, overall stage, and treatment type.